PPARGC1A and prostate carcinoma: To study which components of the CM were responsible for the paracrine activity of PGC1α in prostate cancer cells, we initially separated the CM into two fractions based on molecular weight: 10 kDa (light fraction) and > 10 kDa (heavy fraction) and studied their effects on recipient tumor cells.